![Trulieve Launches "Roll-Up for Justice" Campaign to Support Mission [Green]](/_next/image?url=https%3A%2F%2Fs.yimg.com%2Fcv%2Fapiv2%2Fsocial%2Fimages%2Fyahoo_default_logo-1200x1200.png&w=3840&q=100){kind=logo}
Trulieve Launches "Roll-Up for Justice" Campaign to Support Mission [Green]
"We're thankful for Trulieve's support of Mission [Green] and our fight to free those still paying the price for outdated cannabis laws," said Weldon Angelos, founder of Mission [Green]. "Together, we can turn spare change into real change."
Angelos, a former music producer sentenced to 55 years in prison for selling less than $1,000 of cannabis in 2003, founded Mission [Green] to provide relief for those negatively impacted by cannabis prohibition through clemency and expungement efforts, commissary support, and advocacy for legislative reform.
"Weldon's personal story illustrates the urgent need for cannabis reform," said Trulieve's Chief Executive Officer Kim Rivers. "We are proud to support Mission [Green]'s efforts through the Roll-Up for Justice campaign."
To learn more about the campaign, please visit Trulieve.com.
About Mission [Green]Mission [Green] is a national initiative powered by The Weldon Project, which was created to support individuals disproportionately impacted by cannabis prohibition. The Weldon Project was founded by Weldon Angelos, a former music producer sentenced to 55 years in federal prison for a nonviolent cannabis offense. After receiving a full pardon from President Trump in 2020, Weldon works tirelessly towards criminal justice reform and second-chance advocacy.
About TrulieveTrulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.
Facebook: @Trulieve Instagram: @Trulieve_X: @Trulieve
Investor ContactChristine Hersey, Vice President of Investor Relations+1 (424) 202-0210Christine.Hersey@Trulieve.com
Media ContactPhil Buck, APR, Corporate Communications Manager+1 (406) 370-6226Philip.Buck@Trulieve.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-launches-roll-up-for-justice-campaign-to-support-mission-green-302470704.html
SOURCE Trulieve Cannabis Corp.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/02/c5632.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
6 hours ago
- CBS News
U.S. to probe "anti-American" views of those applying for immigration benefits under Trump directive
The Trump administration has directed government officials to probe any "anti-American" views and activities of immigrants applying for immigration benefits like green cards and work permits, further expanding the grounds that can be cited to deny those applications. The policy unveiled on Tuesday by the U.S. Citizenship and Immigration Services is the latest front in a broader Trump administration effort to restrict access to legal immigration benefits, including by broadening the levels of scrutiny and vetting to which applicants are subjected. The guidance issued this week directs officials at USCIS to determine whether applicants for certain immigration benefits have "endorsed, promoted, supported, or otherwise espoused anti-American views or the views of a terrorist organization or group," including on social media. USCIS said those groups could include organizations that espouse or promote antisemitic views and terrorism. If officials find applicants have any ties to these groups or share their views, the directive instructs the officials to consider that an "overwhelmingly negative factor" justifying the denial of an application. The policy will affect requests for immigration benefits that are discretionary, meaning that USCIS can deny them even if applicants meet the qualifications outlined in U.S. law. Those cases include many applications for permanent U.S. residency (also known as a green card), work permits and status changes for foreign students. While it wasn't immediately clear how expansively USCIS will define "anti-American" views and activities, the agency said it would make the determination based on a provision of U.S. immigration law that bans immigrants from becoming U.S. citizens if it is found that they advocate for world communism, totalitarianism, violence against officials or the overthrow of the U.S. government. The guidance issued Tuesday also orders USCIS officials to probe whether applicants improperly used an immigration policy known as parole to enter the U.S. In the immigration context, parole allows for the arrival of immigrants who are otherwise ineligible to enter the U.S. It was used by the Biden administration on an unprecedented scale, mainly to ease pressure at the U.S.-Mexico border by offering migrants a legal way to enter the country. USCIS said it would look into whether applicants' parole applications contained "false or fraudulent" information. Matthew Tragesser, USCIS' top spokesperson, said Tuesday's memo underscored that U.S. immigration benefits should not be granted to people who "despise the country." "U.S. Citizenship and Immigration Services is committed to implementing policies and procedures that root out anti-Americanism and supporting the enforcement of rigorous screening and vetting measures to the fullest extent possible," Tragesser added. Stephen Yale-Loehr, an expert in U.S. immigration law, expressed concerns about how USCIS would implement its latest guidance, calling the language in it "very subjective." "This memo gives USCIS adjudicators even more reasons than before to deny a petition on discretionary grounds," Yale-Loehr said. While President Trump has made cracking down on illegal immigration central to his second-term agenda, his administration has also tightened access to the legal immigration system. Last week, USCIS said it would expand a "good moral character" assessment in the U.S. citizenship process. That requirement was historically satisfied when applicants lacked serious criminal histories or disqualifying conduct on their record. But now, officials have been instructed to weigh different positive factors, like applicants' involvement in the community, and negative factors, like repeat traffic infractions, to determine whether someone has good moral character. The Trump administration also previously announced measures to more aggressively screen those applying for a U.S. immigration status, including by placing a greater emphasis on the social media activity of applicants.
Yahoo
8 hours ago
- Yahoo
American Tungsten Advances Zero Level Rehabilitation at IMA Mine
Vancouver, BC, Aug. 20, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) ('American Tungsten' or the 'Company') American Tungsten is pleased to report significant progress in the ongoing rehabilitation of the Zero Level portal at its IMA Mine site, as part of its commitment to safety, operational excellence, and regulatory compliance. Weekly Progress Highlights (Week Ending August 16, 2025): Completed installation and lagging of the Zero Level portal entrance Retimbered and reinforced approximately 10 feet of the access tunnel Final leveling and installation of safety berms on the portal pad Finalized preparations to meet MSHA compliance requirements Upcoming Work: Continued re-support and rehabilitation of the Zero Level access drift Removal of the obsolete surface water tank located below the portal 'We are proud of the steady progress at IMA Mine's Zero Level portal. Our team is focused on safety, compliance, and laying the groundwork for future underground operations. These upgrades are essential to ensuring a secure and efficient work environment. As we move forward, we remain committed to investing in the infrastructure and technology that will support long-term exploration and production. The dedication shown by our crews on-site reflects the values we hold as a company—resilience, responsibility, and a forward-looking approach to sustainable production of a critical resource,' said Ali Haji, CEO of American Tungsten. Top left photo: Rebuilt zero level adit portal looking out to excavation equipment Top right photo: Earth moving equipment and generator at IMA Mine ProjectBottom centre photo: Newly constructed Zero level portal at IMA Mine Project Please click to view image Please click to view image About the IMA Mine Project: The IMA Mine is an advanced, readily-permittable, past producing tungsten-molybdenum property situated in the Idaho porphyry belt on private-patented mining claims. American Tungsten has an immediate opportunity to restore production at a strong identified silver and molybdenum-bearing intrusion target in the favourable jurisdiction of Idaho. For further updates, visit or investor relations, Joanna Longo at ir@ ABOUT AMERICAN TUNGSTEN CORP. American Tungsten Corp. is a Canadian exploration company focused on high-potential tungsten and magnetite assets in North America. The Company is advancing the Ima Mine Project in Idaho to commercial production, addressing critical metal scarcity in North America. The Company's Ima Mine Project is a historic and high-quality underground tungsten past-producing property on private-patented land well above the water table with significant infrastructure. The Company holds an exclusive option to acquire full ownership (subject to a 2% royalty) and has expanded its land position with 113 additional federal claims covering nearly 2,000 acres. Social media links:LinkedIn: For further information, please contact: Ali HajiChief Executive OfficerEmail: ahaji@ +1 647 871 4571 CSE:TUNGOTCQB:DEMRFFSE:RK9 The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved the contents of this press release. This news release includes "forward-looking information" that is subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. Forward-looking statements may include but are not limited to, statements relating to the completion of the Offering on the terms described herein or at all, and the use of proceeds and available funds following the completion of the Offering and are subject to all of the risks and uncertainties normally incident to such events. Investors are cautioned that any such statements are not guarantees of future events and that actual events or developments may differ materially from those projected in the forward-looking statements. Such forward-looking statements represent management's best judgment based on information currently available. No securities regulatory authority has either approved or disapproved of the contents of this news release. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
AI-Powered Pathogen Detection App: Provisional Patent Filed by FendX CEO
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), an innovative surface protection company developing their technology-based solutions to reduce the spread of harmful pathogens and support a cleaner, safer world, is pleased to announce that its CEO, Dr. Carolyn Myers, has filed a provisional patent application with the United States Patent and Trademark Office. The application, titled "AI Adaptive App Pathogen Detection Platform" dated June 25, 2025, will be assigned to FendX as part of its expanding portfolio of hygiene-related technologies. The invention described in the patent application is being designed to combine mobile-based imaging, biosensor technology, and artificial intelligence ("AI") to enable real-time detection of pathogens on surfaces using a mobile device such as a smartphone. The aim is to develop a portable, intelligent and user-friendly diagnostic tool for both consumer and professional use. "Traditional diagnostic methods are powerful but often take time to detect and identify pathogens, and they're usually limited to lab settings," said Dr. Carolyn Myers, FendX CEO and inventor. "This invention is part of our ongoing commitment to making surface protection smarter and I believe it shows how mobile devices and AI can work together to bring advanced pathogen detection directly to the user." About FendX Technologies Inc. FendX is a surface protection company leveraging its proprietary technology to develop product solutions that help reduce the spread of harmful pathogens in everyday environments. The Company is advancing an eco-friendly, smart sponge designed to deliver effective cleaning while minimizing environmental impact. This innovative product complements FendX's broader pipeline, which includes REPELWRAP™ film, a protective surface coating with repelling properties that significantly reduce adhesion and transmission of pathogens on high-touch surfaces, and a spray-based coating with similar functionality. Additionally, the Company is developing specialized catheter coatings, with its first coating being for Foley catheters. The Company holds an exclusive supply agreement for the eco-sponge and an exclusive license to certain intellectual property related to the use of the sponge, as well as exclusive worldwide licenses and intellectual property for its coating technologies. ON BEHALF OF THE COMPANY "Carolyn Myers"Carolyn MyersChief Executive Officer and Director Contacts: Dr. Carolyn Myers, CEO and Director1-800-344-9868investor@ For more information, please visit and the Company's profile on SEDAR+ at Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; statements regarding the provisional patent application, invention and goals related to the development of the invention;; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. These statements are only predictions and involve known and unknown risks which may cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking statements, including: risks that the provisional patent application may not receive regulatory approval; adverse market conditions; risks and uncertainties associated with the Company's ability to raise additional capital to complete all of its planned activities including development of the invention;; risks related to research and development activities for each of the film, spray formulation and catheter coating, including successful completion of real world performance testing and scale-up initiatives; risks that the Company may not expand its product pipeline or execute its business development and growth plans; risks that the Company's products, including the eco-friendly sponge, may not be commercialized, and if they are commercialized, that they may not be accepted and adopted by the public; the risk that the Company will not obtain necessary approvals and/or clearances as anticipated or at all; the effects of government regulation on the Company's business; risks associated with the Company's ability to obtain and protect rights to its IP, including the provisional patent application to be assigned to the Company; product candidates only being in formulation/reformulation stages; limited operating history; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other factors beyond the Company's control. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity or performance. Further, any forward-looking statement speaks only as of the date on which such statement is made and, except as required by applicable law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for management to predict all of such factors and to assess in advance the impact of such factors on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement. Readers should consult all of the information set forth herein and should also refer to the risk factor disclosure outlined in the Company's filings with the British Columbia Securities Commission on SEDAR+ at To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
